Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Treated With Lyrica

This study has been completed.

Sponsor:

Information provided by:

Pfizer

ClinicalTrials.gov Identifier:

NCT00541476

First received: October 8, 2007

Last updated: November 20, 2008

Last verified: November 2008

Purpose

The purpose of this study is to obtain more data about efficacy and safety of the study drug Lyrica.

Condition	Phase
Neuralgia	Phase 4

Study Type:	Observational
Study Design:	Time Perspective: Prospective
Official Title:	Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Undergoing Symptomatic Treatment With Lyrica

Further study details as provided by Pfizer:

Enrollment:	746
Study Start Date:	June 2007
Study Completion Date:	December 2007
Primary Completion Date:	December 2007 (Final data collection date for primary outcome measure)

Eligibility

Criteria

Inclusion Criteria:

Exclusion Criteria:

None. Patients recruited by physician decision. Patient's personal data are not collected.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00541476

Sponsors and Collaborators

Pfizer

Investigators

Study Director:

Pfizer CT.gov Call Center

Pfizer

More Information

Additional Information:

No publications provided

Responsible Party:	Director, Clinical Trials Disclosure Group, Pfizer, Inc
ClinicalTrials.gov Identifier:	NCT00541476 History of Changes
Other Study ID Numbers:	A0081178
Study First Received:	October 8, 2007
Last Updated:	November 20, 2008
Health Authority:	Czech Republic: Ethics Committee

Additional relevant MeSH terms:

Neuralgia
Pain
Neurologic Manifestations
Nervous System Diseases

Peripheral Nervous System Diseases
Neuromuscular Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on May 16, 2013